The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: Current concepts and controversies

Seminars in Urologic Oncology

Volumn 20, Issue 4, 2002, Pages 262-271

  Sheinfeld, Joel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Postchemotherapy RPLND; Residual mass; Teratoma

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; TUMOR MARKER; VINBLASTINE;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; EJACULATION; HUMAN; LYMPH NODE DISSECTION; MALE; MINIMAL RESIDUAL DISEASE; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TERATOMA; TREATMENT INDICATION; TUMOR NECROSIS; TUMOR VOLUME;

COMBINED MODALITY THERAPY; GERMINOMA; HUMANS; LYMPH NODE EXCISION; MALE; TESTICULAR NEOPLASMS;

EID: 0036864818     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: 10.1053/suro.2002.36977     Document Type: Review

References (82)

1. Bajorin DF, Herr H, Motzer RJ, et al: Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors. Semin Oncol 19:148-158, 1992
2. Sheinfeld J, Bajorin D, Solomon M: Management of postchemotherapy residual masses in advanced germ cell tumors. AUA Update Series 17:18-24, 1997
3. Merrin C, Yakita H, Becklye S, et al: Treatment of recurrent and widespread testicular tumor by radical reductive surgery and multiple sequential chemotherapy. J Urol 117:291-295, 1976
4. Donohue JP, Einhorn LH, Williams SD: Cytoreductive surgery for melastatic testis cancers. J Urol 123:876-880, 1980
5. Bosl G, Bajorin D, Sheinfeld J, et al: Cancer of the testis, in De Vita V, Hellman S, Rosenberg S (eds): Cancer: Principles and Practice of Oncology. Philadelphia, J B Lippincott, 2000, pp 1491-1518
6. Donohue JP, Roth LM, Zachary JM, et al: Cytoreductive surgery for metastatic testis cancer: Tissue analysis of retroperitoneal masses after chemotherapy. J Urol 127:1111-1114, 1982
7. Donohue JP, Rowland RG: The role of surgery in advanced testis cancer. Cancer 54:2716-2721, 1984
8. Einhorn LH: Testicular cancer as a model for curable neoplasm. The Richard and Hinda Rosental Foundation Award Lecture. Cancer Res 41:3275-3280, 1981
9. Einhorn LH, Williams SD, Mandelbaum I, et al: Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer 48:904-908, 1981
10. Bosl GJ, Gluckman R, Geller NL, et al: VAB-6: An effective chemotherapy regimen for patients with germ cell tumors. J Clin Oncol 4:1493-2499, 1986
11. Peckham MJ: Surveillance following orchiectomy for clinical stage I testicular germ-cell malignancy. Prog Clin Biol Res 203:523-538, 1985
12. Sogani PC, Whitmore WF Jr, Herr HW, et al: Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis. J Clin Oncol 2:267-270, 1984
13. Einhorn LH, Williams SD, Loehrer PJ, et al: Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group protocol. J Clin Oncol 7:387-391, 1989
14. Einhorn LH, Williamss SD, Troner M, et al: The role of maintenance therapy in disseminated testicular cancer. N Engl J Med 305:727-731, 1981
15. Bosl GJ, Geller NL, Bajorin D, et al: A randomized trial of etoposide + cisplatin versus viriblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognostic germ cell tumors. J Clin Oncol 6:1231, 1988
16. Levitt MD, Reynolds PM, Sheiner HG, et al: Nonseminomatous germ cell testicular tumours: Residual masses after chemotherapy. Br J Surg 72:19-22, 1985
17. Fossa SD, Ous S, Lien HH, et al: Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer Urology 141:557-559, 1989
18. Carter GE, Lieskovsky G, Skinner DG, et al: Reassessment of the role of adjunctives surgical therapy in the treatment of advanced germ cell tumors. J Urol 138:1397-1401, 1987
19. Stomper PC, Jochelson MS, Garnick M, et al: Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: Correlation of CT and histology. AJR Am J Roentgenol 145:743-746, 1985
20. Donohue JP, Rowland RG, Kopecky K, et al: Correlation of computerized tomographic changes and histological findings in 80 patients having radical retropentoneal lymph node dissection after chemotherapy for testis tumor. J Urol 137:1176-1179, 1987
21. Gelderman WA, Schraffordt Koops H, Sleifer DT, et al: Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine bleomycin chemotherapy. J Surg Oncol 38:227-232, 1988
22. Levi JA, Thomson D, Dandeman T, et al. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: Role of maintenance and long-term follow-up. J Clin Oncol 6:1154-1160, 1988
23. Wozniak AJ, Samson MK, Shah NT, et al: A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: A Southwest Oncology Group study. J Clin Oncol 9:70-76, 1991
24. Ozols RF, Ihde DC, Linehan WM, et al: A randomized trail of standard chemotherapy versus a high-dose chemotherapy regimen in the treatment of poor prognosis germ cell tumors. J Clin Oncol 6:1031-1040, 1988
25. Williams SD, Birch B, Einhorn D, et al: Treatment of disseminated germ cell tumors with cisplatin, bleomycin and either vinblastine or etoposide. N Engl J Med 316:1435-1440, 1987
26. Fossa SD, Qvist H, Stenwig AK, et al: Is postchemotherapy retroperitoreal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses? J Clin Oncol 10:569-573, 1992
27. Bosl GJ, Geller NL, Chan EY: Stage migration and the increasing proportion of complete responders in patients with advanced germ cell tumors. Cancer Res 48:3524-3527, 1988
28. Sheinfeld J, McKiernan J, Bosl GJ: Surgery of testicular tumors, in Walsh PC, Retik AB, Baughan ED Jr, et al (eds): Campbell's Urology (8th Ed) Philadelphia, WB Saunders, 2002, pp 2920-2944
29. Richie JP, Garnick MB, Finberg H: Computerized tomography: How accurate for abdominal staging of testis tumors? J Urol 127:715-717, 1982
30. Mead GM, Stenning SP, Parkinson MC, et al: The second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. J Clin Oncol 10:85-94, 1991
31. Richie JP: The surgical management of advanced abdominal disease. Semin Urol 2:238-243, 1984
32. Toner GC, Panicek DM, Heelan RT, et al: Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: Recommendations for patient selection. J Clin Oncol 8:1683-1694, 1990
33. Husbard JE, Hawkes DJ, Peckham MJ: CT estimations of mean attention values and volume in testicular carcinoma. Radiology 144:553-558, 1982
34. Debono DJ, Heilman DK, Einhorn LH, et al: Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol 15:1455-1464, 1997
35. Loehrer PJ Sr, Hui S, Clark S, et al: Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: A clinicopathological correlation. J Urol 135:1183-1189, 1983
36. Fossa SD, Aass N, Ous S, et al: Histology of tumor residuals following chemotherapy in patients with advanced non-seminomatous testicular cancer. J Urol 142:1239-1242, 1989
37. Steyerberg EW, Ketzer HG, Fossa SD, et al: Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic seminomatous germ cell tumor: Multivariate analysis of individual patient data from six study groups. J Clin Oucol 13:1177-1187, 1995
38. Steyerberg EW, Gerl A, Fossa SD, et al: Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer. J Clin Oncol 16:269-274, 1998
39. Baniel J, Foster RS, Rowland RG, et al: Complications of primary retroperitoneal lymph node dissection. J Urol 152:424427, 1994
40. Baniel J, Foster RS, Rowland RG, et al: Complications of postchemotherapy retroperitoneal lymph node dissection. J Urol 153:976-980, 1995
41. Nash PA, Leibovitch I, Foster RS, et al: En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: Indications, implications and outcomes J Urol 159:707-710, 1998
42. Beck S, Foster R, Bihrle R, et al: Long term morbidity and survival in patients undergoing vena cava resection for metastatic germ cell tumors. J Urol 161:607A, 1999
43. Kelly R, Skinner D, Yellin AE, et al: En bloc aortic resection for bulky metastatic germ cell tumors. J Urol 153:1849-1851, 1995
44. Hendry WF, A'hern RP, Hetherington JW, et al: Para-aortic lymphadenectomy after chemotherapy for metastatic nonseminomatous germ cell tumours: Prognostic value and therapeutic benefit. Br J Urol 71:208-213, 1993
45. Wood DP Jr, Herr HW, Heller G, et al: Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. J Urol 148:1812-1815, 1992
46. Wahle GR, Foster RS, Bihrle R, et al: Nerve sparing retroperitoneal lymphadenectomy after primary chemotherapy for metastatic testicular carcinoma. J Urol 152:428-430, 1994
47. Donohue JP, Leviovitch I, Foster RS, et al: Integration of surgery and systemic therapy: Results and principles of integration Semin Urol Oncol 16:65-71, 1998
48. Fox EP, Weathers TD, Williams SD, et al: Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. J Clin Oncol 11:1294-1299, 1993
49. Geller N, Bosl G, Chan E: Prognostic factors for relapse after complete response in patients with metastatic germ cell tumors. Cancer 63:440-445, 1989
50. Logothetis C, Samuels M: Surgery in the management of stage III germinal cell tumors Observations on the M. D. Anderson Hospital experience, 1971-1979. Cancer Treat Rev 11:27-37, 1984
51. Logothetis CJ, Samuels ML, Trindade A, et al: The growing teratoma syndrome. Cancer 50:1629-1635, 1982
52. Morgentaler A, Garnick MB, Richie JP: Metastatic testicular teratoma invading the inferior vena cava J Urol 140:149-150, 1988
53. Tait D, Peckham MJ, Hendry WF, et al: Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumors: The significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer 50:601-609, 1984
54. Motzer RJ, Amsterdam A, Prieto V, et al: Teratoma with malignant transformation: Diverse malignant histologies arising in men with germ cell tumors. J Urol 159:133-138, 1998
55. Little JS Jr, Foster RS, Ulbright TM, et al: Unusual neoplasms detected in testis cancer patients undergoing post-chemotherapy retroperitoneal lymphadenectomy. J Urol 152:1144-1149, 1994
56. Ahmed T, Bosl GJ, Hajdu SI: Teratoma with malignant transformation in germ cell tumors in men. Cancer 56:860-863, 1985
57. Ahlgren AD, Simrell CR, Triche TJ, et al: Sarcoma arising in a residual teratoma after cytoreductive chemotherapy. Cancer 54:2015-2018, 1984
58. Ulbright TM, Loehrer PJ, Roth LM, et al: The development on non-germ cell malignancies with germ cell tumors. Cancer 54:1824-1833, 1984
59. Gelderman WA, Schraffordt Koops H, Sleijfer DT, et al: Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy. J Surg Oncol 38:227-232, 1988
60. Borge N, Fossa SD, Ous S, et al: Late recurrence of testicular cancer. J Clin Oncol 6:1248-1253, 1988
61. Gerl A, Clemm C, Schmeller N, et al: Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol 8:41-47, 1997
62. Roth BJ, Greist A, Kubilis PS, et al: Cisplatin-based combination chemotherapy for disseminated germ cell tumors: Longterm follow-up. J Clin Oncol 6:1239-1247, 1988
63. Jansen RL, Sylvester R, Sleyfer DT, et al: Long-term follow up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma of postchemotherapy surgery. EORTC Genitourinary Tract Cancer (EORTC GU Group). Eur J Cancer 27:695-698, 1991
64. Wood DP Jr, Herr HW, Motzer RJ, et al: Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers. Cancer 70:2354-2357, 1992
65. Murphy BR, Breeden ES, Donohue JP, et al: Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 11:324-329, 1993
66. Eastham JA, Wilson TG, Russell C, et al: Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. Urology 43:74-80, 1994
67. Stenning SP, Parkinson MC, Fisher C, et al: Postchemotherapy residual masses in germ cell tumor patients: Content, clinical features, and prognosis. Cancer 83:1409-1419, 1998
68. McKiernan JM, Sheinfeld J, Bacik J, et al: Reoperative RPLND for germ cell tumor; clinical presentation, complications and outcome. J Urol 165:627A, 2001
69. Mandelbaum I, Yaw PB, Einhorn LH, et al: The importance of one-stage median sternotomy and retroperitoneal node dissection in disseminated testicular cancer. Ann Thorac Surg 36:524-528, 1983
70. Qvist HL, Fossa SD, Ous S, et al: Post-chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses? J Urol 145:300-303, 1991
71. Tiffany P, Morse MJ, Bosl G, et al: Sequential excision of residual thoracic and retropentoneal masses after chemotherapy for stage III germ cell tumors. Cancer 57:978-983, 1986
72. Hartmann JT, Candelaria M, Kuczyk MA, et al: Comparison of histologic results from the resection of residual masses at different sites after chemotherapy for metastatic nonseminomatous germ-cell tumors. Eur J Cancer 33:843-847, 1997
73. Steyerberg EW, Keizer HJ, Messemer JE, et al: Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group. Cancer 79:345-355, 1997
74. Tognini PG, Foster RS, McGraw P, et al: Combined post-chemotherapy retroperitoneal lymph node dissection and resection of chest tumor under the same anesthetic is appropriate based on morbidity and tumor pathology [published erratum appears in J Urol 160:1444, 1998]. J Urol 159:1833-1835, 1998
75. McGuire M, Rabbani F, Mohseni H, et al: The role of thoracotomy in the management of postchemotherapy residual thoracic masses. J Urol 161:703A, 1999
76. Mohseni HF, Rabbani F, Leon A, et al: Management and clinical outcome of patients with germ cell tumor and a postchemotherapy residual neck mass. J Urol 167:693A, 2002
77. Brenner PC, Herr HW, Morse MJ, et al: Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis. J Clin Oncol 14:-1765-1769, 1996
78. Aass N, Klepp O, Cavallin-Stahl E, et al: Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: A multicenter experience. J Clin Oncol 9:818-826, 1991
79. Freiha FS, Shortlifle LD, Rouse RV, et al: The extent of surgery after chemotherapy for advanced germ cell tumors. J Urol 132:915-917, 1984
80. Mulder PFA, Oosterhof GON, Boetes C, et al: The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumors. Br J Urol 66:425-429, 1990
81. Harding MJ, Brown IL, MacPherson SG, et al: Excision of residual masses after platinum based chemotherapy for nonseminomatous germ cell tumors. Eur J Cancer Clin Oncol 25:1689-1694, 1989
82. Pizzocaro G, Salvioni R, Pasi M, et al: Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage 11 and bulky stage II nonseminomatous testicular cancer. Cancer 56:249-255, 1985